Breaking the Barriers of Genetic Medicine So No Patient Is Left Behind

Many of today’s most serious diseases persist not because we lack powerful therapeutic ideas, but because we cannot reliably deliver them to the right cells.
‍
Liberate Bio enables genetic medicines to access disease-driving cells directly in the body—reprogramming cellular behavior to cure disease.

A Platform Designed for
Patient Impact

Our RAPTOR™ platform is a scalable discovery system that identifies delivery solutions that work inside the human body (in vivo). By learning from and working with the existing biology, RAPTOR enables genetic payloads to reach specific cell populations that have historically been inaccessible.
‍
Our initial focus has been on delivering to cells that allow us to treat both hematologic cancers and autoimmune disease. This includes both cells in the myeloid lineages (immune cells) and the bone marrow.

platform

From Platform to Patients

Liberate’s first programs apply these capabilities to reprogram immune cells in the blood and in the bone marrow and other organs such as the spleen, demonstrating how delivery unlocks new therapeutic strategies today—while establishing a foundation for broader applications tomorrow.

programs

Revolutionizing genetic medicine takes bold ideas, relentless execution, and the right partners. Let’s build the future—together.

contact us